Why Lung Cancer Screening Is Important Yet So Overlooked | Health Discovered

Lung cancer (https://www.webmd.com/lung-cancer/understanding-lung-cancer-basics) is the second most common cancer in the United States. An estimated 238,340 people in the U.S. will be diagnosed with lung cancer in 2023, and 64% of lung cancers are diagnosed at stage III or IV. With all of these facts (https://www.webmd.com/lung-cancer/lung-cancer-statistics), it’s surprising that lung cancer screening (https://www.webmd.com/lung-cancer/lung-cancer-screening-tests), a tool that could save lives, is rarely used. Why is that? Who does that impact the most? And what changes can be made? We spoke with Jeff Yang, MD (https://www.massgeneral.org/doctors/21047/chi-fu-jeffrey-yang), a thoracic surgeon at Massachusetts General Hospital and founder of the American Lung Cancer Screening Initiative (https://www.alcsi.org/), about symptoms (https://www.webmd.com/lung-cancer/understanding-lung-cancer-symptoms), recommended lung cancer screenings, and available treatment options. We then spoke with Narjust Florez, MD (https://www.dana-farber.org/find-a-doctor/narjust-florez/), associate director of the Cancer Care Equity Program (https://www.dana-farber.org/research/departments-centers-and-labs/departments-and-centers/cancer-care-equity-program/) and a thoracic medical oncologist at Dana-Farber Cancer Institute, about the stigma and lung cancer patients experience and how patients can better advocate for themselves.

None (https://www.webmd.com/lung-cancer/lung-cancer-screening-in-smokers)

Episode link: https://play.headliner.app/episode/17667922?utm_source=youtube